To clarify whether CDKN2A SCND could drive GC metastasis, we analysed the prevalence of CDKN2A SCNVs by P16-Light among 234 GC patients enrolled in the cross-sectional study (26). This evidence concerns the gene CDKN2A and gastric cancer.